To assess the possible interactions among candidate anti-influenza agents, dual combinations of rimantadine, ribavirin, 2′-deoxy-2′-fluoroguanosine (2-FDG) and 4-guanidino-Neu5Ac2en (GG167) were tested against clinical isolates of influenza A H3N2 and H1N1 subtype viruses in MDCK cells by ELISA. Each of the dual combinations showed additive effects, except for the combination of 2-FDG and ribavirin which was synergistic against the influenza A (H1N1) virus. However, this combination also showed enhanced cytotoxicity. In this assay system, influenza agents with differing mechanisms of antiviral interaction interacted in an additive fashion with respect to inhibition of viral replication.
BurlingtonD.B.MeiklejohnG., and MostowS.R. (1983) Anti-influenza A activity of combinations of amantadine and ribavirin in ferret tracheal ciliated epithelium. J Antimicrob Chemother11: 7–14.
2.
DegelauJ.SomaniS.K.CooperS.L.GuayD.R.P., and CrossleyK.B. (1992) Amantadine-resistant influenza A in a nursing facility. Arch Intern Med152: 390–392.
3.
ErikssonB.HelgstrandE.JohnanssonN.G.LarssonA.MisiornyA.NorenJ.O.PhilipsonL.StenbergL.SteningG.StridhS., and ObergB. (1977) Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother11: 946–951.
4.
HaydenF.G. (1986) Combinations of antiviral agents for treatment of influenza virus infections. J Antimicrob Chemother18 (Suppl B): 177–183.
5.
HaydenF.G.DouglasR.G.Jr., and SimonsR. (1980) Enhancement of activity against influenza viruses by combinations of antiviral agents. Antimicrob Agents Chemother18: 536–541.
6.
HaydenF.G.SchlepushkinA.N., and PushkarskayaN.L. (1984) Combined interferon-α2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro. Antimicrob Agents Chemother25: 53–57.
7.
HaydenF.G.BelsheR.B.CloverR.D.HayA.J.OakesM.G., and SooW. (1989) Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med321: 1696–1702.
8.
HaydenF.RollinsB., and MadrenL. (1994) Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium. Antiviral Res25: 123–131.
9.
MastE.E.HarmonM.W.GravensteinS.WuS.ArdenN.H.CircoR.TyszkaG.KendalA.P., and DavisJ.P. (1991) Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Amer J Epidemiol134: 988–997.
10.
PrichardM.N., and ShipmanC.Jr (1990) A three-dimensional model to analyze drug-drug interactions. Antiviral Res14: 181–206.
11.
PrichardM.N.AseltineK.R., and ShipmanC.Jr (1992) MacSynergy™ II.University of Michigan, Ann Arbor, Ml.
12.
RollinsB.S.ElkhatiebA.H.A., and HaydenF.G. (1993) Comparative anti-influenza virus activity of 2′-deoxy-2′-fluororibosides in vitro. Antiviral Res21: 357–368.
13.
RyanD.M.TicehurstJ., and DempseyM.H. (1994) The anti-influenza virus activity of a novel neuraminidase (sialidase) inhibitor 4-Guanidino Neu5Ac2en. Antiviral Res23 (Suppl.): 77.
14.
ScholtissekC. (1976) Inhibition of influenza RNA synthesis by virazole (Ribavirin). Archives Virology50: 349–352.
15.
SkehanP.StorengR.ScudieroD.MonksA.McMahonJ.VisticaD.WarrenJ.T.BokeschH.KenneyS., and BoydeM.R. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst82: 1107–1112.
16.
TisdaleM.AppleyardG.TuttleJ.V.NelsonD.J.Nusinoff-LehrmanS.al NakibW.StablesU.N.PurifoyD.J.M.PowellK.L., and DarbyG. (1993a) Inhibition of influenza A and B viruses by 2′-deoxy-2′-fluororibosides. Antiviral Chem Chemother4: 281–287.
17.
TisdaleM.EllisM.CourtS., and FordM. (1993b) Specific inhibition of influenza transcriptase by 2′-deoxy-2′-fluoroguanosine. Antiviral Res20 (Suppl.) 100.
18.
TisdaleM.LoweD.StablesJ.JakemanK.J., and SweetC. (1994) Single dose efficacy of 2′-fluorodGuo in the mouse and ferret influenza models. Antiviral Res23: 142 (abst 201).
19.
von ItzsteinM.WuW.KokG.B.PeggM.S.DyasonJ.C.JinB.van PhanT.SmytheM.L.WhiteH.F.OliverS.W.ColmanP.M.VargheseJ.N.RyahD.M.WoodsJ.M.BethellR.C.HathanV.J.CameronJ.M., and PennC.R. (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature363: 418–423.
20.
WilsonS.Z.KnightV.WydeP.R.DrakeS., and CouchR.B. (1980) Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. Antimicrob Agents Chemother17: 642–648.
21.
WoodsJ.M.BethellR.C.CoatesJ.A.V.HealyN.HiscoxS.A.PearsonB.A.RyanD.M.TicehurstJ.TillingJ.WalcottS.M., and PennC.R. (1993) 4-Guanidino-2,4-Dideoxy-2,3-Dehydro-N-Acetylneraminic Acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob Agents Chemother37: 1473–1479.
22.
WrayS.K.GilbertB.E., and KnightV. (1985) Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. Antiviral Res5: 39–48.
